<DOC>
	<DOC>NCT01553435</DOC>
	<brief_summary>Effect of N-methyl D-aspartate (NMDA) receptor antagonist Dextromethorphan on Opiods analgesia and tolerance in Pediatric Intensive Care Unit Patients</brief_summary>
	<brief_title>Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients</brief_title>
	<detailed_description />
	<mesh_term>N-Methylaspartate</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Inclusion: Patients above 2 years, admitted in PICU On Morphine or Fentanyl infusions for more than 48 hours Patients under 2 years of age Patients with anticipated PICU length of stay less than 3 days. Patients shall be excluded if Morphine or Fentanyl infusions not continued for the minimum duration of 72 hours after enrollment Patients develops hemodynamic instability Patients with Hepatic failure Withdrawal request by parent(s)/guardian/family</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Dextromethorphan</keyword>
	<keyword>Morphine</keyword>
	<keyword>Fentanyl</keyword>
	<keyword>Opioid</keyword>
	<keyword>analgesia</keyword>
	<keyword>Efficacy</keyword>
</DOC>